Publications
Contact Us
May H. Abdelaziz, BPharm, MS, PhD
Principal Investigator
Assistant Professor, Pharmaceutical Sciences Department
WTB Room 368
Email: mabdelaziz@uttyler.edu
Phone: 903.566.6231
Michael Willis
Administrative Assistant
WTB Room 341
Email: mwillis@uttyler.edu
Phone: 903.566.6299
Fisch College of Pharmacy
The University of Texas at Tyler
W.T. Brookshire Hall
3900 University Blvd.
Tyler, TX 75799
Recent Peer Reviewed Publications
Updated Publication List
Signaling Crosstalk in Staphylococcus aureus Two-component Systems Network. L Ali
and MH Abdel Aziz#. (2024) J. Bacteriol. 206(4):e0041823
Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative
as a human Topoisomerase I inhibitor with efficacy against bone cancer cells and colon
adenocarcinoma. AI Khodair, SM El-Hallouty, B Cagle-White, MH Abdel Aziz, MK Hanafy,
S Mowafy, NM Hamdy, SE Kassab. (2024) Eur. J. Med. Chem. 265: 116049.
A Scoping Review of Artificial Intelligence within Pharmacy Education. MH Abdel Aziz#,
C Rowe, R Southwood, A Nogid, S Berman, K Gustafson. (2024) Am. J. Pharm. Educ. 88:
100615.
NH125 Sensitizes Staphylococcus aureus to Cell Wall Targeting Antibiotics through
the Inhibition of VraS Sensor Histidine Kinase. S Bhattarai. L Marsh, K Knight, L
Ali, A Gomez, A Sunderhaus, MH Abdel Aziz#. (2023) Microbiol. Spectr. 11(3):e0486122.
Pharmacy students’ perceptions and attitudes toward face-to-face vs. virtual team-based
learning (TBL) in the didactic curriculum: A mixed-methods study. O Shoair, WJ Smith,
MH Abdelaziz, M Veronin, J Glavy, S Pirtle. (2023) Med Educ Online 28(1):2226851.
A FOXC2 inhibitor, MC-1-F2, as a therapeutic candidate for targeting EMT in castration-resistant
prostate cancer. M Castaneda, L Rodriguez; J Oh; B Cagle-White; H Suh; MH Abdel Aziz,
J Lee. Bioorg. Med. Chem. Lett. 91 (2023) 129369.
Recent Invited Presentations
Medicinal Chemistry: Healing by Design. MH Abdelaziz. Presented at ACS National Chemistry
Week. UT Tyler, October 16, 2023.
The Effect of the Staphylococcus aureus Histidine Kinase VraS Mutations on Catalysis,
Substrate Affinity, and Antibiotic Resistance. MH Abdelaziz. Presented at UT Health
Science Center at Tyler. May 30, 2023.
Kinases: At the Crossroads of Human and Bacterial Cell Signaling. MH Abdelaziz. Presented
at the FCOP Research Seminar Series. May 9, 2023.
Biomedical Research APPEs: Opportunities and Challenges. MH Abdelaziz. Presented at
the FCOP Preceptor Conference. December 10, 2022.
Engineered tyrosine kinase receptor dimers as a drug discovery tool. MH Abdelaziz.
Podium Presentation at the Southern Biomedical Engineering Conference. August 27,
2022.
Recent Posters/Presentations
The Effect of VraS Single Point Mutation on Staphylococcus aureus Gene Expression
during Vancomycin Shock: A Bioinformatic Analysis. S Karki, L Ali, S Srivastava, MH
Abdelaziz. Presented at the UT Tyler Lyceum, Tyler, TX. April 26, 2024.
Exploring Crosstalk Interactions in the Two-Component System Signaling Network of
Staphylococcus aureus. D Al-manaseer, A Mattern, L Ali, S Karki, and MH Abdelaziz.
Presented at the UT Tyler Lyceum, Tyler, TX. April 26, 2024.
Molecular Mechanism of Pseudomonas-induced Activation of Epidermal Growth Factor Receptor.
E Nwachukwu, S Fancher, B Cagle-White, MH Abdel Aziz, D Patterson, A Azghani. Presented
at the East Texas Research Conference. Tyler, TX. April 12, 2024.
The effect of Staphylococcus aureus’ VraS kinase domain mutations on VraR interaction
affinity and activation. A Solis, B Cagle-White, L Marsh, S Bhattarai, MH Abdel Aziz.
Presented at the National American Society of Microbiology Conference, Houston, TX.
June 16, 2023.
The impact of Staphylococcus aureus VraS histidine kinase mutation on antibiotic resistance.
L Ali, B Cagle-White, K Knight, MH Abdel Aziz. Presented at the National American
Society of Microbiology Conference, Houston, TX. June 18, 2023.
Engineering polycaprolactone composite nanofiber as antibacterial wound healing scaffolds.
I Montoya, S Karki, S Sulthana, S Aryal, O Alsmairat, MH Abdel Aziz. Presented at
the UT Tyler Lyceum, Tyler, TX. April 14, 2023.
Investigating the Mechanism of Pseudomonas-induced Activation of Epidermal Growth
Factor Receptor in vitro. E Nwachukwu, B Cagle-White, MH Abdel Aziz, A Azghani. Presented
at the Texas Branch–American Society for Microbiology. March 25, 2023.
Design and characterization of electrospun nanofiber membrane for antibacterial drug
delivery.
S Karki, A Neelam, B Cagle-White, A Solis, L Ali, O Alsmairat, S Aryal, MH Abdel Aziz.
Presented at the Southern Biomedical Engineering Conference. August 26, 2022. (Third
place, Undergraduate Student Poster Award).
Exploring the effect of mutations on the activity and stability of the bacterial histidine
kinase VraS. E Scott, A Sunderhaus, S Bhattarai, K Catague, B Cagle-White, MH Abdel
Aziz. Presented at the ACS National Meeting. March 21, 2022.
Activation of VraS histidine kinase by T331I mutation linked to antibiotic resistance.
S Bhattarai, A Sunderhaus, L Marsh, and MH Abdel Aziz. Selected for the “Live Poster”
session at the ACS National Meeting. April 10, 2021.
Modulation of VraS Sensor Histidine Kinase Activity and Inhibition in Presence of
its Response Regulator VraR. L Marsh, S Bhattarai, A Sunderhaus, P Epie, and MH Abdel
Aziz. Presented at the Texas Academy of Science. February 27, 2021.
Contact Us
May H. Abdelaziz, BPharm, MS, PhD
Principal Investigator
Assistant Professor, Pharmaceutical Sciences Department
WTB Room 368
Email: mabdelaziz@uttyler.edu
Phone: 903.566.6231
Michael Willis
Administrative Assistant
WTB Room 341
Email: mwillis@uttyler.edu
Phone: 903.566.6299
Fisch College of Pharmacy
The University of Texas at Tyler
W.T. Brookshire Hall
3900 University Blvd.
Tyler, TX 75799